Association of biomarkers and response to immune checkpoint inhibitors (ICIs) in patients with metastatic urothelial carcinoma (mUC) with high and low tumor mutation burden (TMB).

被引:0
作者
Jindal, Tanya
Zhu, Xiaolin
Zhang, Li
Reyes, Kevin R.
Deshmukh, Prianka
de Kouchkovsky, Ivan
Kumar, Vipul
Maldonado, Edward
Shipp, Chase
Kwon, Daniel H.
Borno, Hala
Bose, Rohit
Desai, Arpita
Aggarwal, Rahul Raj
Porten, Sima P.
Small, Eric Jay
Fong, Lawrence
Chou, Jonathan
Friedlander, Terence W.
Koshkin, Vadim S.
机构
[1] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA
[2] UCSF Hem Onc Fellowship, San Francisco, CA USA
[3] Univ Calif San Francisco, San Francisco, CA USA
[4] Univ Calif San Francisco, Med Ctr, San Francisco, CA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
534
引用
收藏
页数:1
相关论文
empty
未找到相关数据